Alzheimer’s disease affects over 55 million people worldwide and has long been linked to toxic protein buildup and chronic inflammation in the brain.

Explore how adaptive immunity influences Alzheimer’s disease, its impact on disease progression, and potential therapeutic ...

In a new publication, bioengineered multimodal nanofilaments uncloak cancer cells and recruit both innate and adaptive immune systems to eradicate tumorsSHERBROOKE, Québec--(BUSINESS ...

Bucking the trend of IL-12 therapy program failures, Imunon’s IMNN-001 was bolstered by positive translational data in ...

CERo Therapeutics Holdings ( ($CERO) ) has shared an update. On September 22, 2025, CERo Therapeutics Holdings updated its corporate presentation, ...

Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second ...

The NF-κB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory ...

Understanding the intricate workings of a chicken's gastrointestinal tract is crucial for optimising their health and ...

The NF-kB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory diseases where NF-kB plays a central role. Additionally, the expected ...

IMNN-001 continues to show a favorable safety profile.

Working unconventional hours disrupts the body’s internal clock, which in turn affects the immune system and increases people ...